More than ever, life sciences companies are going public to raise capital for future growth. In fact, U.S. equity financing in life sciences skyrocketed to a record $7 billion in 2018—a…
Read the full article at: www.jdsupra.com
↧
To IPO, Or Not to IPO, That Is the Question – How to prepare for and execute a successful public offering | Pepper Hamilton LLP – JDSupra
↧